Keyphrases
Nuclear Magnetic Resonance Imaging
75%
Magnetic Resonance Imaging
67%
Micro Magnetic Resonance Imaging
56%
Allopurinol
56%
Ischemic Heart Disease
56%
Clubfoot
56%
Image Data
47%
High-resolution
47%
Tumor
46%
Courgette
44%
Plant Tissue
42%
Cardiovascular Outcomes
39%
Cardiovascular Magnetic Resonance Imaging
37%
Inhomogeneous Magnetic Field
37%
Multinuclear NMR
37%
Muscle Atrophy
37%
Mutant Mice
37%
Gluten
37%
Magnetic Resonance Imaging Analysis
37%
GDC-0941
37%
Gene-deficient Mice
37%
Cardiovascular Disease
37%
Whole-body
37%
Atherosclerotic Burden
37%
Water Protons
36%
Image Contrast
34%
Transverse Relaxation
34%
Lipids
34%
Usual Care
32%
B Cells
29%
Follicular Lymphoma
29%
Avian Embryo
28%
Quail Embryo
28%
NMR Spectra
28%
Pulse Sequence
28%
Talipes Equinovarus
27%
Three-dimensional Magnetic Resonance Imaging
25%
Atheroma
23%
Wheat Gluten
23%
Relaxation Studies
23%
Prospective Randomized Trial
23%
Peripheral Arterial Disease
22%
Heteronuclear
22%
Spatial Distribution
22%
Type 2 Diabetes Mellitus (T2DM)
21%
Embryonic Development
20%
Peroneal
20%
Cohort Comparison
18%
Non-diabetic Adults
18%
Butter Beans
18%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Allopurinol
56%
Ischemic Heart Disease
56%
Acute Lymphocytic Leukemia
56%
Cardiovascular System
51%
Neoplasm
42%
Cardiac Magnetic Resonance Imaging
37%
Cardiovascular Disease
37%
Clubfoot
37%
B Cell
27%
Follicular Lymphoma
27%
Foot Malformation
24%
Arteriosclerosis Obliterans
22%
Patient Population
18%
Heart Disease
18%
Proton Nuclear Magnetic Resonance
18%
Phosphoinositide 3-Kinase Inhibitor
18%
DeJerine-Sottas Disease
18%
Randomized Controlled Trial
18%
Lower Leg
18%
Mammalian Target of Rapamycin
18%
Carcinogenesis
18%
Insulin Resistance
18%
Protein Kinase B
18%
Maturity Onset Diabetes of the Young
17%
Myocardial Infarction
17%
Tensin
12%
Phosphatase
12%
Gout
12%
Apoplexy
11%
3D Imaging
11%
Coronary Artery Disease
11%
Azd 8055
10%
Arm
10%
Chick Embryo
9%
Limb
9%
Pulse Rate
9%
Steady State
9%
Diabetes
9%
Stenosis
9%
Diseases
9%
Hazard Ratio
8%
Malignant Neoplasm
8%
Vascular Disease
7%
Cerebrovascular Disease
7%
Intention-to-Treat Analysis
7%
Care Group
6%
Efficacy Study
6%
Tumor Progression
6%
Tumor Regression
6%